Illumina has joined a Canadian genomics testing consortium including bio-pharma giants the Personalized Medicine Initiative, Pfizer and Sanofi. The Nation Access Project managed by AstraZeneca (PMI) is bringing personalized molecularly-based medicine to Canadian patients, by basing medical treatment selection on the individual's genetic tumour profile. Contextual Genomics, the molecular testing company providing the tests, states the Goal of the initiative is "to deliver standardized clinical cancer testing" by unifying the multiple molecular tests into a single test.
Illumina has joined a Canadian genomics testing consortium including bio-pharma giants AstraZeneca, Pfizer and Sanofi. The Nation Access Project managed by the Personalized Medicine Initiative (PMI) is bringing personalized molecularly-based medicine to Canadian patients, by basing medical treatment selection on the individual's genetic tumour profile. Contextual Genomics, the molecular testing company providing the tests, states the Goal of the initiative is "to deliver standardized clinical cancer testing" by unifying the multiple molecular tests into a single test.